The Ledger

Oura, the smart-ring maker, agreed to buy the AI primary care company Counsel Health for a reported $625 million in cash, weeks after reportedly shelving its IPO. UPDATE on our September 22 coverage of Oura’s planned $2.2 billion initial public offering (IPO). Oura’s announcement post, dated November 10, says it signed a definitive agreement and expects to close near the end of this year. The post gives no price. The $625 million figure, paid in cash subject to customary adjustments, and a close before the end of 2026 come from HIT Consultant and HLTH, which credits Reuters. Counsel’s founder, Dr. Muthu Alagappan, would become Oura’s chief clinical AI officer. Oura has partnered with Counsel since May 2026, and the post says Counsel will keep working with health plans and health systems, including for people who do not wear a ring. Trade reports put Oura at about 6 million members and say its revenue rose 153% in the latest quarter, though outlets label that quarter differently and Oura’s post gives no figures. Who it hits: virtual primary care operators, the health plans and employers that buy virtual care, and any wearable company weighing a clinical arm. So what: a consumer device company with millions of members now owns a physician-supervised care operation, which moves the contest for the first visit toward the wrist and toward the data a ring collects. Neither the post nor the reports mention regulatory approvals or say how Counsel’s physicians are employed or licensed by state. Confidence: Med; the price rests on trade press citing Reuters, and no Oura filing or release with the price was posted where we could read it.

P3 Health Partners swung to $30.8 million of third quarter net income from a $69.5 million loss, but its medical margin leaned on favorable settlements and its cash is thin. The physician-group operator, which takes financial risk for Medicare Advantage patients, said in its third quarter press release, dated November 9, that revenue rose 15% to $396.3 million and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $20.9 million against a $45.9 million loss a year ago. Medical margin was $43.9 million, but $35.0 million excluding favorable payer settlements and prior-year development, so about $8.9 million came from those items. At-risk members fell 9% to about 105,000, which the company attributes to deliberate network and payer cuts. Full-year guidance is revenue of $1.525 billion to $1.6 billion, medical margin of $260 million to $300 million and adjusted EBITDA of $90 million to $110 million, with the low end of that last range raised; the release does not state the prior ranges. Cash was $43.9 million against $84.4 million of debt due within a year, and nine-month operating cash flow was negative $90.1 million, funded by $110.3 million of financing, including $56.5 million of net preferred stock proceeds. The release does not state a medical loss ratio. Who it hits: health plans that contract with risk-bearing physician groups, and investors and operators in the value-based care sector, where Medicare Advantage cost trend decides who survives. So what: the turnaround is real on EBITDA, but it comes with a smaller risk book and a balance sheet still funded by new capital. Going-concern language appears only in the release’s boilerplate risk list. Confidence: High on the figures, which come from the release; we did not read the 10-Q.

A note on today’s scan: Wednesday morning was thin on new primary-source finance items. We found no health system rating actions, bankruptcies or hospital earnings dated November 10 or 11. We found no new filing in the Redeemer Health bankruptcy, no new terms on the Surgery Partners amendment covered Monday, and no new terms on the Option Care Health or Definitive Healthcare proposals. Frontier scan: we checked surgical robotics and pharmacy automation and found no deal dated this month; the most recent items were Stryker’s October 12 option on CMR Surgical and Enovis’s $180 million offer for eCential Robotics, both outside the window.

THE DEAL SHEET

One transaction spotted in the last 24 hours. The price is not in Oura’s own post; it comes from HIT Consultant.